Ngā hua rapu kaituhi

1

COVID-19 in Cladribine-treated patient with multiple sclerosis mā Haham, Nitsan, Vaknin-Dembinsky, Adi

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Effects of Supermagnetic Iron Oxide Labeling on the Major Functional Properties of Human Mesenchymal Stem Cells from Multiple Sclerosis Patients mā Kassis, Ibrahim, Vaknin-Dembinsky, Adi, Bulte, Jeff, Karussis, Dimitrios

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3 mā Mizrachi, Tehila, Vaknin-Dembinsky, Adi, Brenner, Talma, Treinin, Millet

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS mā Vaknin-Dembinsky, Adi, Brass, Steven, Gandhi, Roopali, Weiner, Howard L.

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis mā Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis mā Vaknin-Dembinsky, Adi, Murugaiyan, Gopal, Hafler, David A., Astier, Anne L., Weiner, Howard L.

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Interferon-beta Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis mā Balashov, Konstantin E., Aung, Latt Latt, Vaknin-Dembinsky, Adi, Dhib-Jalbut, Suhayl, Weiner, Howard L.

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Description of 3 patients with myasthenia gravis and COVID-19 mā Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis mā Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course mā Rechtman, Ariel, Brill, Livnat, Zveik, Omri, Uliel, Benjamin, Haham, Nitzan, Bick, Atira S., Levin, Netta, Vaknin-Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes mā Zveik, Omri, Rechtman, Ariel, Haham, Nitzan, Adini, Irit, Canello, Tamar, Lavon, Iris, Brill, Livnat, Vaknin-Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells mā Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) mā Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica mā Nechemia, Yael, Moreh, Elior, Weingarden, Harold, Bloch, Ayala, Givon, Uri, Vaknin-Dembinsky, Adi, Schwartz, Isabella, Meiner, Zeev, Zeilig, Gabi

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 mā Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab mā Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() mā Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness mā Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel mā Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab mā Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Vaknin-Dembinsky, Adi

COVID-19 in Cladribine-treated patient with multiple sclerosis mā Haham, Nitsan, Vaknin-Dembinsky, Adi

Effects of Supermagnetic Iron Oxide Labeling on the Major Functional Properties of Human Mesenchymal Stem Cells from Multiple Sclerosis Patients mā Kassis, Ibrahim, Vaknin-Dembinsky, Adi, Bulte, Jeff, Karussis, Dimitrios

Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3 mā Mizrachi, Tehila, Vaknin-Dembinsky, Adi, Brenner, Talma, Treinin, Millet

Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS mā Vaknin-Dembinsky, Adi, Brass, Steven, Gandhi, Roopali, Weiner, Howard L.

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis mā Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi

Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis mā Vaknin-Dembinsky, Adi, Murugaiyan, Gopal, Hafler, David A., Astier, Anne L., Weiner, Howard L.

Interferon-beta Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis mā Balashov, Konstantin E., Aung, Latt Latt, Vaknin-Dembinsky, Adi, Dhib-Jalbut, Suhayl, Weiner, Howard L.

Description of 3 patients with myasthenia gravis and COVID-19 mā Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis mā Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course mā Rechtman, Ariel, Brill, Livnat, Zveik, Omri, Uliel, Benjamin, Haham, Nitzan, Bick, Atira S., Levin, Netta, Vaknin-Dembinsky, Adi

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes mā Zveik, Omri, Rechtman, Ariel, Haham, Nitzan, Adini, Irit, Canello, Tamar, Lavon, Iris, Brill, Livnat, Vaknin-Dembinsky, Adi

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells mā Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) mā Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris

Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica mā Nechemia, Yael, Moreh, Elior, Weingarden, Harold, Bloch, Ayala, Givon, Uri, Vaknin-Dembinsky, Adi, Schwartz, Isabella, Meiner, Zeev, Zeilig, Gabi

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 mā Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab mā Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness mā Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel mā Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab mā Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi

Ngā utauta rapu: